


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.42%
+15.38%
-17.88%
ACXP
Acurx Pharmaceuticals
$2.90
ACXP Price Performance
$2.09 (+38.76%)
$4.11 (-29.44%)
$7.59 (-61.79%)
$0.44 (+559.09%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
ACXP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ACXP Street Sentiment is extremely bullish and have positive views on the near-term outlook
ACXP has Extreme risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
What is ACXP current stock price?
What are ACXP stock strengths?
What is ACXP Risk Level?
What is ACXP market cap and volume?
What is ACXP current Stock IQ?
Should I buy ACXP stock right now?
Is ACXP a Strong Buy right now?
What does a 'Strong Buy' rating mean for ACXP?
What does a 'Strong Sell' rating mean for ACXP?
What factors influence ACXP's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ACXP
Acurx Pharmaceuticals
Current Price
$2.90

ACXP Price Performance
$2.09 (+38.76%)
$4.11 (-29.44%)
$7.59 (-61.79%)
$0.44 (+559.09%)
ACXP Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
ACXP Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ACXP Street Sentiment is extremely bullish and have positive views on the near-term outlook
ACXP has Extreme risk level
Risk Indicators
Average key support and resistance price levels
ACXP Stock IQ
Stock Insights
Not Enough Information
ACXP Latest Analysis
Acurx Pharma To Conduct New Ibezapolstat Clinical Trial In RCDI. Advances Phase 3 Trial For CDI . (RTTNews) - Acurx Pharmaceuticals Inc. (ACXP) a late-stage biopharmaceutical company announced that it will conduct a new clinical trial with Ibezapolstat in patients with recurrentClostridioides difficileInfection (rCDI).In parallel the firm is advancing to Phase 3 interna
Tue Mar 10, 2026
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors. Acurx Pharmaceuticals Inc. (NASDAQ:ACXP) is one of the best up and coming penny stocks to buy. On February 2 Acurx Pharmaceuticals announced that the United States Patent and Trademark Office granted a new patent US 12534470 covering its DNA Polymerase IIIC inhibitors. This patent includes compositions-of-matter methods of use and pharmaceutical compositions reinforcing the companys [….]
Tue Feb 24, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ACXP Stock trends
ACXP Stock performance
ACXP Stock analysis
ACXP investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.